SCHEMBL30636907

SCHEMBL30636907

CC(C)Oc1cnoc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12896156 0.72 CYP2C9 (0.37) —
SCHEMBL14348160 0.64 FLT1 (0.34) —
SCHEMBL12896055 0.64 CHRNB2 (0.38) —
SCHEMBL125543 0.63 ALDH1A3 (0.64) —
SCHEMBL8370932 0.63 ALDH1A1 (0.44) —
SCHEMBL12896071 0.62 ALDH1A3 (0.35) —
SCHEMBL713041 0.62 ALDH1A3 (0.35) —
SCHEMBL8811944 0.61 — —
SCHEMBL24326416 0.60 ALDH1A3 (0.34) —
SCHEMBL355299 0.60 MAP4K4 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12024524-B2 Imidazopyridazines as modulators of IL-17 JANSSEN PHARMACEUTICA NV (BE) 2024-07-02 — — US disclosed
US-20230357254-A1 IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17 JANSSEN PHARMACEUTICA NV (BE) 2023-11-09 — — US disclosed
Send feedback